<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Light-based, adjunctive, and other therapies for acne vulgaris
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Light-based, adjunctive, and other therapies for acne vulgaris
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Light-based, adjunctive, and other therapies for acne vulgaris
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jeffrey S Dover, MD, FRCPC
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Priya Batra, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Robert P Dellavalle, MD, PhD, MSPH
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Moise L Levy, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Cindy Owen, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Abena O Ofori, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Oct 25, 2021.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Acne vulgaris is a common condition, and there is significant demand for effective acne therapies. Many over-the-counter products are marketed. In addition, a number of procedural therapies are utilized for the treatment of acne vulgaris with variable effectiveness.
        </p>
        <p>
         The use of over-the-counter and light-based therapies as well as several adjunctive therapies (office-based chemical peels, microdermabrasion, comedo extraction, intralesional glucocorticoids, and heat therapy) will be reviewed here. Conventional therapies, hormonal therapy, and
         <a class="drug drug_general" data-topicid="8582" href="/z/d/drug information/8582.html" rel="external">
          isotretinoin
         </a>
         therapy for acne vulgaris are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/42.html" rel="external">
          "Acne vulgaris: Overview of management"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/38.html" rel="external">
          "Oral isotretinoin therapy for acne vulgaris"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/129467.html" rel="external">
          "Acne vulgaris: Management of moderate to severe acne in adolescents and adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          OTHER TOPICAL MEDICATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         For many people with acne, treatment begins with nonprescription regimens. Numerous products are available, and nonprescription treatments are effective for some individuals. Some of the most common ingredients found in nonprescription acne products include salicylic acid,
         <a class="drug drug_general" data-topicid="8811" href="/z/d/drug information/8811.html" rel="external">
          benzoyl peroxide
         </a>
         , sulfur, and alpha hydroxy acids. Tea tree oil has also been used for treatment of acne. In July 2016, the US Food and Drug Administration (FDA) approved
         <a class="drug drug_general" data-topicid="9352" href="/z/d/drug information/9352.html" rel="external">
          adapalene
         </a>
         0.1% gel for over-the-counter use, making it the first topical retinoid approved for distribution directly to consumers. (See
         <a class="medical medical_review" href="/z/d/html/42.html" rel="external">
          "Acne vulgaris: Overview of management"
         </a>
         .)
        </p>
        <p>
         Patients with mild to moderate acne who do not respond to nonprescription products after three months of treatment should be clinically evaluated. Patients with more severe acne should be evaluated earlier, to consider the use of the most effective treatment regimens to prevent or minimize scarring.
        </p>
        <p>
         Topical nonprescription acne therapies are generally well tolerated. However, rare but serious and potentially life-threatening hypersensitivity reactions to nonprescription topical acne products containing salicylic acid or
         <a class="drug drug_general" data-topicid="8811" href="/z/d/drug information/8811.html" rel="external">
          benzoyl peroxide
         </a>
         have been reported [
         <a href="#rid1">
          1
         </a>
         ]. Whether these active ingredients or inactive ingredients are responsible for the reactions is unclear. Symptoms may occur within minutes to one day or longer after product use and may include severe skin reactions, throat tightness, difficulty breathing, feeling faint, or swelling of the eyes, face, lips, or tongue. The US FDA recommends limiting application of these products to one or two small affected areas during the initial three days of use to test for hypersensitivity [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h2">
          Salicylic acid
         </span>
         <span class="headingEndMark">
          —
         </span>
         Salicylic acid (0.5 to 2%) is a beta hydroxy acid available in a number of nonprescription gels, lotions, solutions, cleansers, pads, and masks. It is a desquamating agent, and its lipophilic properties enable it to penetrate the pilosebaceous follicle, producing a comedolytic effect [
         <a href="#rid2">
          2
         </a>
         ].
         <a class="drug drug_general" data-topicid="10254" href="/z/d/drug information/10254.html" rel="external">
          Topical salicylic acid
         </a>
         also possesses mild anti-inflammatory properties. Salicylic acid is usually applied once daily and subsequently increased to two or three times per day if needed [
         <a href="#rid3">
          3
         </a>
         ]. The frequency of application can be reduced to once daily or every other day if the patient develops skin dryness or peeling [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p>
         In three placebo-controlled studies, salicylic acid was an effective treatment for acne [
         <a href="#rid4">
          4
         </a>
         ]. It is a treatment option for patients who cannot tolerate topical retinoids or
         <a class="drug drug_general" data-topicid="8811" href="/z/d/drug information/8811.html" rel="external">
          benzoyl peroxide
         </a>
         [
         <a href="#rid5">
          5,6
         </a>
         ]. Salicylic acid can also be used in combination with benzoyl peroxide, as the mechanisms of action of these drugs complement each other in the treatment of acne. (See
         <a class="medical medical_review" href="/z/d/html/42.html" rel="external">
          "Acne vulgaris: Overview of management", section on 'Benzoyl peroxide'
         </a>
         .)
        </p>
        <p>
         Higher concentrations of salicylic acid may be used in the office to perform superficial chemical peels. (See
         <a class="local">
          'Office-based superficial chemical peels'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Benzoyl peroxide
         </span>
         <span class="headingEndMark">
          —
         </span>
         <a class="drug drug_general" data-topicid="8811" href="/z/d/drug information/8811.html" rel="external">
          Benzoyl peroxide
         </a>
         is a commonly used antimicrobial acne treatment that also possesses comedolytic properties. The drug is an effective treatment for inflammatory and comedonal acne. It is available in both nonprescription and prescription formulations. (See
         <a class="medical medical_review" href="/z/d/html/42.html" rel="external">
          "Acne vulgaris: Overview of management", section on 'Benzoyl peroxide'
         </a>
         .)
        </p>
        <p>
         The combination of
         <a class="drug drug_general" data-topicid="8811" href="/z/d/drug information/8811.html" rel="external">
          benzoyl peroxide
         </a>
         and salicylic acid may be useful for patients who desire a nonprescription regimen [
         <a href="#rid2">
          2,7
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Sulfur
         </span>
         <span class="headingEndMark">
          —
         </span>
         Topical sulfur has been used for the treatment of acne for many years, although there are few data supporting its efficacy [
         <a href="#rid8">
          8
         </a>
         ]. The mechanism of action remains unknown. It is thought that sulfur interacts with cysteine in keratinocytes, resulting in the production of hydrogen sulfide, which has a keratolytic effect [
         <a href="#rid9">
          9
         </a>
         ]. Sulfur also inhibits the proliferation of
         <em>
          Cutibacterium
         </em>
         (formerly
         <em>
          Propionibacterium
         </em>
         )
         <em>
          acnes
         </em>
         [
         <a href="#rid8">
          8
         </a>
         ]. Older formulations of sulfur were sometimes offensive to patients due to an unpleasant, rotten egg-like odor. This odor is minimized in newer formulations.
        </p>
        <p>
         Sulfur is often combined with salicylic acid in nonprescription products. In addition, sulfur has been studied in combination with
         <a class="drug drug_general" data-topicid="8811" href="/z/d/drug information/8811.html" rel="external">
          benzoyl peroxide
         </a>
         . In a case series of 113 patients with acne, a combination of 2.5 to 5% sulfur and 10% benzoyl peroxide was efficacious for the majority of patients [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p>
         Prescription products that combine sulfur with
         <a class="drug drug_general" data-topicid="9958" href="/z/d/drug information/9958.html" rel="external">
          sulfacetamide
         </a>
         , an ingredient with antibacterial properties, are available and have been effective in open-label studies [
         <a href="#rid11">
          11,12
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          Alpha hydroxy acids
         </span>
         <span class="headingEndMark">
          —
         </span>
         The most commonly used alpha hydroxy acids are glycolic acid and lactic acid. Alpha hydroxy acids are weak organic acids that cause desquamation and diminish corneocyte cohesion, thereby normalizing follicular keratinization [
         <a href="#rid13">
          13
         </a>
         ]. These agents may also promote dispersing of basal layer melanin, which can help to improve postinflammatory hyperpigmentation.
        </p>
        <p>
         Alpha hydroxy acids in low concentrations and buffered alpha hydroxy acids in higher concentrations are available as over the counter washes, lotions, creams, and at-home peel systems. High concentrations with more free acid are used in the office to perform superficial chemical peels. (See
         <a class="local">
          'Office-based superficial chemical peels'
         </a>
         below.)
        </p>
        <p>
         Only low-quality evidence is available regarding the use of low concentrations of alpha hydroxy acids for the treatment of acne. Alpha hydroxy acids may be most effective as components of a treatment regimen containing other acne medications [
         <a href="#rid14">
          14
         </a>
         ]. Glycolic acid is generally considered to be less effective than
         <a class="drug drug_general" data-topicid="10014" href="/z/d/drug information/10014.html" rel="external">
          topical tretinoin
         </a>
         , when used as monotherapy. However, a synergistic effect has been observed when the two medications are combined [
         <a href="#rid13">
          13
         </a>
         ].
        </p>
        <p>
         Alpha hydroxy acids also diminish the signs of aging skin, and are marketed for use in antiaging skin care regimens.
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h2">
          Tea tree oil
         </span>
         <span class="headingEndMark">
          —
         </span>
         Tea tree oil is a product derived from the Australian Melaleuca alternifolia tree that possesses antimicrobial and anti-inflammatory properties. Two randomized controlled trials have investigated this agent for the management of acne vulgaris. In a 45-day trial of 60 patients with mild to moderate acne vulgaris, patients treated with 5% tea tree oil exhibited a 44 percent reduction in total lesion counts, compared with a 12 percent reduction in the placebo group [
         <a href="#rid15">
          15
         </a>
         ]. In another trial comparing treatment with 5% tea tree oil or 5%
         <a class="drug drug_general" data-topicid="8811" href="/z/d/drug information/8811.html" rel="external">
          benzoyl peroxide
         </a>
         (n = 124), patients in both groups showed a significant reduction in inflammatory and noninflammatory acne lesions, but a slower onset of action occurred with tea tree oil therapy [
         <a href="#rid16">
          16
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h1">
          LIGHT/LASER THERAPIES
         </span>
         <span class="headingEndMark">
          —
         </span>
         Clinician-administered light sources are used for the treatment of acne, though well-designed clinical trials supporting the benefit of these treatments are limited, and there is uncertainty about the efficacy of these interventions [
         <a href="#rid17">
          17
         </a>
         ]. Examples of light-based therapies include [
         <a href="#rid18">
          18
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Broad-spectrum continuous-wave visible light sources (blue light, red light)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Intense pulsed light
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Laser sources including the potassium titanyl phosphate (KTP) laser, pulsed dye laser (PDL), and infrared lasers
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Photodynamic therapy
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Photopneumatic technology
        </p>
        <p>
        </p>
        <p>
         Photodynamic therapy involves the application of a photosensitizing agent such as
         <a class="drug drug_general" data-topicid="9199" href="/z/d/drug information/9199.html" rel="external">
          aminolevulinic acid
         </a>
         (ALA) or methyl aminolevulinic acid (MAL) prior to exposure to blue or red light, lasers, pulsed light sources, or nonpulsed broad spectrum light. It is hypothesized that once applied to the skin, ALA and MAL are preferentially taken up by the pilosebaceous unit and augment the response to light therapy [
         <a href="#rid19">
          19
         </a>
         ]. Additional topical photosensitizers that have been less extensively studied in photodynamic therapy for acne include
         <a class="drug drug_general" data-topicid="8982" href="/z/d/drug information/8982.html" rel="external">
          indocyanine green
         </a>
         and indole-3-acetic acid [
         <a href="#rid20">
          20,21
         </a>
         ].
        </p>
        <p>
         Photopneumatic technology is a newer therapeutic modality. It has been less extensively studied for the treatment of acne than other light treatments. Photopneumatic devices combine gentle negative pressure with broadband pulsed light (400 to 1200 nm). The suction pressure helps to open follicular ostia through the evacuation of sebum and brings pilosebaceous units closer to the treatment tip. The broadband light exerts antibacterial and anti-inflammatory effects [
         <a href="#rid22">
          22-24
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h2">
          Mechanism of action
         </span>
         <span class="headingEndMark">
          —
         </span>
         The mechanisms of action for light-based therapies in the treatment of acne are not completely understood. Proposed theories regarding the mechanisms through which these modalities work include the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Blue and red light therapy for acne are thought to work via the absorption of light by porphyrins produced by
         <em>
          C. acnes
         </em>
         [
         <a href="#rid25">
          25,26
         </a>
         ]. The porphyrins absorb light wavelengths between 400 and 700 nm, and absorb most effectively at wavelengths around 410 nm, which is within the absorption spectrum of blue light. As a result of light exposure, the porphyrins become activated, leading to the production of free oxygen radicals and bacterial death. Red light activates porphyrins less intensely than blue light, but penetrates more deeply into the skin.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Infrared lasers (1320 nm, 1450 nm), radiofrequency devices, and photodynamic therapy are thought to inflict thermal damage to sebaceous glands and decrease sebum production. Photodynamic therapy also reduces obstruction of follicles, hyperkeratosis, and inflammation within acne lesions [
         <a href="#rid27">
          27
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Intense pulsed light (400 to 1200 nm), pulsed dye lasers (585 to 595 nm), and KTP lasers (532 nm) may function through inhibition of
         <em>
          C. acnes
         </em>
         and/or damage to the sebaceous glands [
         <a href="#rid28">
          28
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h2">
          Efficacy
         </span>
         <span class="headingEndMark">
          —
         </span>
         The efficacy of light-based therapies for the treatment of acne vulgaris remains under investigation. High-quality data to support a recommendation for routine use of light-based therapies are lacking [
         <a href="#rid17">
          17
         </a>
         ].
        </p>
        <p>
         Although many articles on the use of photodynamic therapy in acne have been published, as with other light-based interventions, the efficacy of this intervention remains unclear. There is a lack of consensus regarding the optimal treatment protocol: the best photosensitizer, the best photosensitizer delivery method, the ideal contact time, the preferred light source and light dose, and the optimal treatment interval remain to be determined [
         <a href="#rid29">
          29
         </a>
         ]. Photodynamic therapy is also associated with side effects that are unacceptable for some patients (eg, erythema, crusting, pain, and postinflammatory dyspigmentation) [
         <a href="#rid19">
          19,30
         </a>
         ].
        </p>
        <p>
         Only a few studies have compared light-based treatments with traditional acne therapies [
         <a href="#rid17">
          17
         </a>
         ]. As an example, a small randomized controlled trial found blue-red light more effective than 5%
         <a class="drug drug_general" data-topicid="8811" href="/z/d/drug information/8811.html" rel="external">
          benzoyl peroxide
         </a>
         for treatment of inflammatory lesions, with a 17.6 percent difference in mean percentage improvement [
         <a href="#rid31">
          31
         </a>
         ]. No difference in treatment efficacy was noted in small randomized controlled trials of blue light therapy versus
         <a class="drug drug_general" data-topicid="9275" href="/z/d/drug information/9275.html" rel="external">
          clindamycin
         </a>
         1% solution (n = 34) [
         <a href="#rid32">
          32
         </a>
         ], intense pulsed light plus benzoyl peroxide versus benzoyl peroxide alone (n = 30) [
         <a href="#rid33">
          33
         </a>
         ], or pulsed-dye laser treatment plus topical clindamycin/benzoyl peroxide versus topical clindamycin/benzoyl peroxide alone [
         <a href="#rid34">
          34
         </a>
         ]. In another small randomized trial, improvement in inflammatory lesions with photodynamic therapy was found to be less than that with
         <a class="drug drug_general" data-topicid="9352" href="/z/d/drug information/9352.html" rel="external">
          adapalene
         </a>
         0.1% gel [
         <a href="#rid35">
          35
         </a>
         ].
        </p>
        <p>
         Additional randomized controlled trials and comparative treatment studies are necessary to clarify the role for laser and other light-based therapies in the treatment of acne. Continued research may also be useful for identifying new light-based therapies that will be useful for acne. An in vitro study found that laser wavelengths of 1720 nm were able to selectively target sebaceous glands without damaging adjacent skin structures [
         <a href="#rid36">
          36
         </a>
         ]. If laser treatments at this wavelength are determined to be safe and effective, this may present a future treatment option for acne.
        </p>
        <p class="headingAnchor" id="H115312527">
         <span class="h2">
          Emerging therapy
         </span>
         <span class="headingEndMark">
          —
         </span>
         The findings of two small randomized trials suggest that topical application of light-absorbing gold microparticles followed by exposure to an 800 nm diode laser may improve inflammatory acne [
         <a href="#rid37">
          37
         </a>
         ]. The treatment causes selective photothermolysis of sebaceous glands.
        </p>
        <p class="headingAnchor" id="H503483933">
         <span class="h2">
          Home-use devices
         </span>
         <span class="headingEndMark">
          —
         </span>
         The use of home-use, handheld devices for acne, particularly those using light-emitting diode, is gaining popularity. Although there have been small studies published supporting its efficacy and safety, high-quality, peer-reviewed data are lacking [
         <a href="#rid38">
          38
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h1">
          ADJUNCTIVE THERAPIES
         </span>
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h2">
          Office-based superficial chemical peels
         </span>
         <span class="headingEndMark">
          —
         </span>
         Superficial chemical peels are most appropriate for patients with primarily comedonal acne, and work to quicken the process of comedone resolution [
         <a href="#rid39">
          39
         </a>
         ]. Of note, multiple treatments are required, results are temporary, and improvement may be mild [
         <a href="#rid3">
          3
         </a>
         ]. Glycolic acid (an alpha hydroxy acid) and salicylic acid (a beta hydroxy acid) are the most common agents utilized. Resorcinol, lactic acid,
         <a class="drug drug_general" data-topicid="10296" href="/z/d/drug information/10296.html" rel="external">
          trichloroacetic acid
         </a>
         , and pyruvic acid may also be used.
        </p>
        <p>
         High-quality, placebo-controlled efficacy trials are lacking. A randomized trial and several case series have supported the efficacy of glycolic acid and salicylic acid chemical peels [
         <a href="#rid40">
          40-43
         </a>
         ]. The split-face randomized trial (n = 20) compared the treatment of facial acne with glycolic acid peels versus salicylic acid peels [
         <a href="#rid40">
          40
         </a>
         ]. After 12 weeks, the treatments were similarly effective for the reduction of acne lesions. However, at two months post treatment, only the salicylic acid-treated areas maintained a significant decrease in the number of acne lesions.
        </p>
        <p>
         Patients on oral retinoids should
         <strong>
          not
         </strong>
         be treated with chemical peels due to the potential for significant irritation. It is also recommended that patients on topical retinoids discontinue treatment for several days prior to treatment with chemical peels. Patients with skin phototypes IV to VI  (
         <a class="graphic graphic_table graphicRef60541" href="/z/d/graphic/60541.html" rel="external">
          table 1
         </a>
         ) are at increased risk of postinflammatory hypo- or hyperpigmentation, and care must be taken to minimize this risk.
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h2">
          Microdermabrasion
         </span>
         <span class="headingEndMark">
          —
         </span>
         Microdermabrasion is a noninvasive procedure in which abrasive crystals (eg, aluminum oxide) are propelled onto the skin within a controlled vacuum suction system, leading to exfoliation of the stratum corneum. Microdermabrasion was reported to show benefit in a nonrandomized pilot study (n = 24) comparing severity of acne in photographs before and after treatment [
         <a href="#rid44">
          44
         </a>
         ]. Patients continued to adjust acne medications throughout the study period, and the severity assessment was not quantitative. Thus, the effectiveness of microdermabrasion has been called into question [
         <a href="#rid45">
          45
         </a>
         ].
        </p>
        <p>
         Microdermabrasion may have benefit as a pretreatment for photodynamic therapy to decrease incubation time of the topical photosensitizer [
         <a href="#rid39">
          39,46
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h2">
          Comedo extraction
         </span>
         <span class="headingEndMark">
          —
         </span>
         Mechanical removal of comedones can be a useful adjunct to topical therapy in patients with resistant comedones [
         <a href="#rid3">
          3
         </a>
         ]. Pretreatment with tretinoin cream for four to six weeks often facilitates the procedure [
         <a href="#rid47">
          47
         </a>
         ].
        </p>
        <p>
         To perform the extraction, gently excise the roof or enlarge the opening of the comedo with an 18-gauge needle, sterile lancet, or no. 11 blade. Gently but firmly apply pressure with a comedo extractor to the skin to remove the keratin plug or milial cyst through the opening of the extractor.
         <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">
          Lidocaine
         </a>
         /
         <a class="drug drug_general" data-topicid="10228" href="/z/d/drug information/10228.html" rel="external">
          prilocaine
         </a>
         cream (EMLA) may be applied under an occlusive dressing for 1.5 to 2 hours prior to the procedure for anesthesia. Scarring is a potential risk.
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h2">
          Intralesional glucocorticoids
         </span>
         <span class="headingEndMark">
          —
         </span>
         Intralesional glucocorticoids are a treatment option for nodular acne lesions that might otherwise take weeks to resolve. Treated lesions typically flatten in 48 to 72 hours, improving appearance and discomfort [
         <a href="#rid48">
          48
         </a>
         ].
         <a class="drug drug_general" data-topicid="10015" href="/z/d/drug information/10015.html" rel="external">
          Triamcinolone
         </a>
         acetonide, in concentrations of 1.25 to 2.5 mg/mL, is typically injected using a 30-gauge needle.
        </p>
        <p>
         There is no high-quality evidence demonstrating the efficacy of such injections, but extensive clinical experience supports their use. Lower concentrations of
         <a class="drug drug_general" data-topicid="10015" href="/z/d/drug information/10015.html" rel="external">
          triamcinolone
         </a>
         may be as effective as higher concentrations and may reduce the risk of adverse effects; in one small randomized trial, lesions treated with 0.63, 1.25, or 2.5 mg/mL of triamcinolone acetonide exhibited similar improvement scores [
         <a href="#rid48">
          48
         </a>
         ].
        </p>
        <p>
         Patients should be cautioned regarding potential side effects including cutaneous atrophy, hypopigmentation, and telangiectasias. (See
         <a class="medical medical_review" href="/z/d/html/5568.html" rel="external">
          "Intralesional corticosteroid injection"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h2">
          Heat
         </span>
         <span class="headingEndMark">
          —
         </span>
         The US Food and Drug Administration approved a home device (ThermaClear) that provides a pulse of heat for acne treatment. An unpublished five-day trial of the device compared heat treatment on one side of the face with no treatment on the other side [
         <a href="#rid49">
          49
         </a>
         ]. A blinded analysis of photographs found that a greater percentage of treated lesions (44 versus 11 percent of untreated lesions) completely cleared. Other available devices include Zeno and the Radiancy Clear Touch Lite Acne Clearance System [
         <a href="#rid50">
          50
         </a>
         ]. The latter uses a combination of heat and pulsed light.
        </p>
        <p>
         Because of the lack of published studies supporting their efficacy and safety, heat sources are not recommended as first-line treatments for acne.
        </p>
        <p class="headingAnchor" id="H663164">
         <span class="h2">
          Diet
         </span>
         <span class="headingEndMark">
          —
         </span>
         The relationship between diet and acne is controversial, but several studies published in the last decade suggest that dietary modifications may affect acne severity. The data on diet and acne are reviewed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/39.html" rel="external">
          "Pathogenesis, clinical manifestations, and diagnosis of acne vulgaris", section on 'Diet'
         </a>
         .)
        </p>
        <p>
         Additional study is needed prior to a recommendation for dietary changes in the treatment of acne [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3383349060">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/114928.html" rel="external">
          "Society guideline links: Acne vulgaris"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topics (see
         <a class="medical medical_basics" href="/z/d/html/15326.html" rel="external">
          "Patient education: Acne (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beyond the Basics topics (see
         <a class="medical medical_patient" href="/z/d/html/7634.html" rel="external">
          "Patient education: Acne (Beyond the Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Numerous nonprescription products are available for the treatment of acne. Common ingredients in nonprescription products include salicylic acid,
         <a class="drug drug_general" data-topicid="8811" href="/z/d/drug information/8811.html" rel="external">
          benzoyl peroxide
         </a>
         , sulfur, and alpha hydroxy acids.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For patients with mild to moderate acne who do not want to initiate prescription medications, we suggest a trial of
         <a class="drug drug_general" data-topicid="8811" href="/z/d/drug information/8811.html" rel="external">
          benzoyl peroxide
         </a>
         and/or salicylic acid (
         <a class="grade" href="https:///uptodate/show/grade_5" rel="external">
          Grade 2B
         </a>
         ). For patients with inflammatory lesions, benzoyl peroxide is preferred due to the drug's antimicrobial properties. Combination therapy with both drugs may lead to additional benefit. Patients with mild to moderate acne who do not respond to nonprescription products after three months of treatment should be clinically evaluated. Patients with more severe acne should be evaluated earlier, to consider use of more effective treatments to prevent or minimize irreversible scarring. (See
         <a class="local">
          'Other topical medications'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/42.html" rel="external">
          "Acne vulgaris: Overview of management"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The role of laser and other light-based therapies in the treatment of acne is not clearly defined. We suggest that light-based therapies should not be used as first-line treatment for acne vulgaris (
         <a class="grade" href="https:///uptodate/show/grade_5" rel="external">
          Grade 2B
         </a>
         ). These therapies may be utilized as an adjunct to medical acne therapy or as an option for patients who decline medical therapy although further studies are necessary to clarify their role. (See
         <a class="local">
          'Light/laser therapies'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In patients with primarily comedonal acne who desire an accelerated treatment response, we suggest superficial chemical peels (
         <a class="grade" href="https:///uptodate/show/grade_5" rel="external">
          Grade 2B
         </a>
         ). However, peels should be avoided in patients taking oral
         <a class="drug drug_general" data-topicid="8582" href="/z/d/drug information/8582.html" rel="external">
          isotretinoin
         </a>
         and should be used with caution in patients with dark skin pigmentation. (See
         <a class="local">
          'Office-based superficial chemical peels'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Until further evidence is available, we suggest not using microdermabrasion for the treatment of acne (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). However, this procedure may be useful as a pretreatment for photodynamic therapy. (See
         <a class="local">
          'Microdermabrasion'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         We suggest intralesional glucocorticoids for selected nodular inflammatory acne lesions in order to accelerate their resolution (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). Patients should be warned of the potential side effects of cutaneous atrophy, hypopigmentation, and telangiectasias prior to treatment. (See
         <a class="local">
          'Intralesional glucocorticoids'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li class="breakAll">
          www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm402722.htm?source=govdelivery&amp;utm_medium=email&amp;utm_source=govdelivery (Accessed on June 26, 2014).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bowe WP, Shalita AR. Effective over-the-counter acne treatments. Semin Cutan Med Surg 2008; 27:170.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol 2016; 74:945.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zander E, Weisman S. Treatment of acne vulgaris with salicylic acid pads. Clin Ther 1992; 14:247.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gollnick H, Cunliffe W, Berson D, et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 2003; 49:S1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Strauss JS, Krowchuk DP, Leyden JJ, et al. Guidelines of care for acne vulgaris management. J Am Acad Dermatol 2007; 56:651.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seidler EM, Kimball AB. Meta-analysis comparing efficacy of benzoyl peroxide, clindamycin, benzoyl peroxide with salicylic acid, and combination benzoyl peroxide/clindamycin in acne. J Am Acad Dermatol 2010; 63:52.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gupta AK, Nicol K. The use of sulfur in dermatology. J Drugs Dermatol 2004; 3:427.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lin AN, Reimer RJ, Carter DM. Sulfur revisited. J Am Acad Dermatol 1988; 18:553.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilkinson RD, Adam JE, Murray JJ, Craig GE. Benzoyl peroxide and sulfur: foundation for acne management. Can Med Assoc J 1966; 95:28.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tarimci N, Sener S, Kilinç T. Topical sodium sulfacetamide/sulfur lotion. J Clin Pharm Ther 1997; 22:301.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Breneman DL, Ariano MC. Successful treatment of acne vulgaris in women with a new topical sodium sulfacetamide/sulfur lotion. Int J Dermatol 1993; 32:365.
          </a>
         </li>
         <li class="breakAll">
          Lewis AB, Radoszyck H. Alpha-hydroxy acids. In: Comprehensive Dermatologic Drug Therapy, 2nd ed, Wolverton SE (Ed), Elsevier, 2007. p.730.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tung RC, Bergfeld WF, Vidimos AT, Remzi BK. alpha-Hydroxy acid-based cosmetic procedures. Guidelines for patient management. Am J Clin Dermatol 2000; 1:81.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Enshaieh S, Jooya A, Siadat AH, Iraji F. The efficacy of 5% topical tea tree oil gel in mild to moderate acne vulgaris: a randomized, double-blind placebo-controlled study. Indian J Dermatol Venereol Leprol 2007; 73:22.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bassett IB, Pannowitz DL, Barnetson RS. A comparative study of tea-tree oil versus benzoylperoxide in the treatment of acne. Med J Aust 1990; 153:455.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barbaric J, Abbott R, Posadzki P, et al. Light therapies for acne. Cochrane Database Syst Rev 2016; 9:CD007917.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haedersdal M, Togsverd-Bo K, Wulf HC. Evidence-based review of lasers, light sources and photodynamic therapy in the treatment of acne vulgaris. J Eur Acad Dermatol Venereol 2008; 22:267.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hamilton FL, Car J, Lyons C, et al. Laser and other light therapies for the treatment of acne vulgaris: systematic review. Br J Dermatol 2009; 160:1273.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jang MS, Doh KS, Kang JS, et al. A comparative split-face study of photodynamic therapy with indocyanine green and indole-3-acetic acid for the treatment of acne vulgaris. Br J Dermatol 2011; 165:1095.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim BJ, Lee HG, Woo SM, et al. Pilot study on photodynamic therapy for acne using indocyanine green and diode laser. J Dermatol 2009; 36:17.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Omi T, Munavalli GS, Kawana S, Sato S. Ultrastructural evidence for thermal injury to pilosebaceous units during the treatment of acne using photopneumatic (PPX) therapy. J Cosmet Laser Ther 2008; 10:7.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shamban AT, Enokibori M, Narurkar V, Wilson D. Photopneumatic technology for the treatment of acne vulgaris. J Drugs Dermatol 2008; 7:139.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wanitphakdeedecha R, Tanzi EL, Alster TS. Photopneumatic therapy for the treatment of acne. J Drugs Dermatol 2009; 8:239.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee WL, Shalita AR, Poh-Fitzpatrick MB. Comparative studies of porphyrin production in Propionibacterium acnes and Propionibacterium granulosum. J Bacteriol 1978; 133:811.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ashkenazi H, Malik Z, Harth Y, Nitzan Y. Eradication of Propionibacterium acnes by its endogenic porphyrins after illumination with high intensity blue light. FEMS Immunol Med Microbiol 2003; 35:17.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sakamoto FH, Lopes JD, Anderson RR. Photodynamic therapy for acne vulgaris: a critical review from basics to clinical practice: part I. Acne vulgaris: when and why consider photodynamic therapy? J Am Acad Dermatol 2010; 63:183.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thiboutot D, Gollnick H, Bettoli V, et al. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. J Am Acad Dermatol 2009; 60:S1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morton CA, Szeimies RM, Sidoroff A, Braathen LR. European guidelines for topical photodynamic therapy part 2: emerging indications--field cancerization, photorejuvenation and inflammatory/infective dermatoses. J Eur Acad Dermatol Venereol 2013; 27:672.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Taylor MN, Gonzalez ML. The practicalities of photodynamic therapy in acne vulgaris. Br J Dermatol 2009; 160:1140.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Papageorgiou P, Katsambas A, Chu A. Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris. Br J Dermatol 2000; 142:973.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gold MH, Rao J, Goldman MP, et al. A multicenter clinical evaluation of the treatment of mild to moderate inflammatory acne vulgaris of the face with visible blue light in comparison to topical 1% clindamycin antibiotic solution. J Drugs Dermatol 2005; 4:64.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chang SE, Ahn SJ, Rhee DY, et al. Treatment of facial acne papules and pustules in Korean patients using an intense pulsed light device equipped with a 530- to 750-nm filter. Dermatol Surg 2007; 33:676.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Karsai S, Schmitt L, Raulin C. The pulsed-dye laser as an adjuvant treatment modality in acne vulgaris: a randomized controlled single-blinded trial. Br J Dermatol 2010; 163:395.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yeung CK, Shek SY, Bjerring P, et al. A comparative study of intense pulsed light alone and its combination with photodynamic therapy for the treatment of facial acne in Asian skin. Lasers Surg Med 2007; 39:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sakamoto FH, Doukas AG, Farinelli WA, et al. Selective photothermolysis to target sebaceous glands: theoretical estimation of parameters and preliminary results using a free electron laser. Lasers Surg Med 2012; 44:175.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Paithankar DY, Sakamoto FH, Farinelli WA, et al. Acne Treatment Based on Selective Photothermolysis of Sebaceous Follicles with Topically Delivered Light-Absorbing Gold Microparticles. J Invest Dermatol 2015; 135:1727.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hession MT, Markova A, Graber EM. A review of hand-held, home-use cosmetic laser and light devices. Dermatol Surg 2015; 41:307.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kempiak SJ, Uebelhoer N. Superficial chemical peels and microdermabrasion for acne vulgaris. Semin Cutan Med Surg 2008; 27:212.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kessler E, Flanagan K, Chia C, et al. Comparison of alpha- and beta-hydroxy acid chemical peels in the treatment of mild to moderately severe facial acne vulgaris. Dermatol Surg 2008; 34:45.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Atzori L, Brundu MA, Orru A, Biggio P. Glycolic acid peeling in the treatment of acne. J Eur Acad Dermatol Venereol 1999; 12:119.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee HS, Kim IH. Salicylic acid peels for the treatment of acne vulgaris in Asian patients. Dermatol Surg 2003; 29:1196.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grimes PE. The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. Dermatol Surg 1999; 25:18.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lloyd JR. The use of microdermabrasion for acne: a pilot study. Dermatol Surg 2001; 27:329.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Spencer JM. Microdermabrasion. Am J Clin Dermatol 2005; 6:89.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Katz BE, Truong S, Maiwald DC, et al. Efficacy of microdermabrasion preceding ALA application in reducing the incubation time of ALA in laser PDT. J Drugs Dermatol 2007; 6:140.
          </a>
         </li>
         <li class="breakAll">
          Goldstein BG, Goldstein AO. Diagnostic procedures. In: Practical Dermatology, 2nd ed, Mosby-year Book, Inc, 1997. p.26.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Levine RM, Rasmussen JE. Intralesional corticosteroids in the treatment of nodulocystic acne. Arch Dermatol 1983; 119:480.
          </a>
         </li>
         <li class="breakAll">
          www.thermaclear.com/clinical-results.cfm (Accessed on May 22, 2009).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Badgwell Doherty C, Doherty SD, Rosen T. Thermotherapy in dermatologic infections. J Am Acad Dermatol 2010; 62:909.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 37 Version 25.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm402722.htm?source=govdelivery&amp;utm_medium=email&amp;utm_source=govdelivery" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm402722.htm?source=govdelivery&amp;utm_medium=email&amp;utm_source=govdelivery (Accessed on June 26, 2014).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18786494" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Effective over-the-counter acne treatments.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26897386" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Guidelines of care for the management of acne vulgaris.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1535287" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Treatment of acne vulgaris with salicylic acid pads.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12833004" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Management of acne: a report from a Global Alliance to Improve Outcomes in Acne.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17276540" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Guidelines of care for acne vulgaris management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20488582" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Meta-analysis comparing efficacy of benzoyl peroxide, clindamycin, benzoyl peroxide with salicylic acid, and combination benzoyl peroxide/clindamycin in acne.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15303787" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : The use of sulfur in dermatology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2450900" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Sulfur revisited.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4223133" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Benzoyl peroxide and sulfur: foundation for acne management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9548212" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Topical sodium sulfacetamide/sulfur lotion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8505165" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Successful treatment of acne vulgaris in women with a new topical sodium sulfacetamide/sulfur lotion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8505165" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Successful treatment of acne vulgaris in women with a new topical sodium sulfacetamide/sulfur lotion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11702315" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : alpha-Hydroxy acid-based cosmetic procedures. Guidelines for patient management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17314442" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : The efficacy of 5% topical tea tree oil gel in mild to moderate acne vulgaris: a randomized, double-blind placebo-controlled study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2145499" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : A comparative study of tea-tree oil versus benzoylperoxide in the treatment of acne.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27670126" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Light therapies for acne.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18221341" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Evidence-based review of lasers, light sources and photodynamic therapy in the treatment of acne vulgaris.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19239470" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Laser and other light therapies for the treatment of acne vulgaris: systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21692772" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : A comparative split-face study of photodynamic therapy with indocyanine green and indole-3-acetic acid for the treatment of acne vulgaris.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19207432" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Pilot study on photodynamic therapy for acne using indocyanine green and diode laser.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18330792" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Ultrastructural evidence for thermal injury to pilosebaceous units during the treatment of acne using photopneumatic (PPX) therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18335650" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Photopneumatic technology for the treatment of acne vulgaris.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19271370" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Photopneumatic therapy for the treatment of acne.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/637914" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Comparative studies of porphyrin production in Propionibacterium acnes and Propionibacterium granulosum.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12589953" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Eradication of Propionibacterium acnes by its endogenic porphyrins after illumination with high intensity blue light.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20633796" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Photodynamic therapy for acne vulgaris: a critical review from basics to clinical practice: part I. Acne vulgaris: when and why consider photodynamic therapy?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19376456" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23181556" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : European guidelines for topical photodynamic therapy part 2: emerging indications--field cancerization, photorejuvenation and inflammatory/infective dermatoses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19239465" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : The practicalities of photodynamic therapy in acne vulgaris.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10809858" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15696987" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : A multicenter clinical evaluation of the treatment of mild to moderate inflammatory acne vulgaris of the face with visible blue light in comparison to topical 1% clindamycin antibiotic solution.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17550443" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Treatment of facial acne papules and pustules in Korean patients using an intense pulsed light device equipped with a 530- to 750-nm filter.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20394631" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : The pulsed-dye laser as an adjuvant treatment modality in acne vulgaris: a randomized controlled single-blinded trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17252567" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : A comparative study of intense pulsed light alone and its combination with photodynamic therapy for the treatment of facial acne in Asian skin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22170298" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Selective photothermolysis to target sebaceous glands: theoretical estimation of parameters and preliminary results using a free electron laser.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25748556" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Acne Treatment Based on Selective Photothermolysis of Sebaceous Follicles with Topically Delivered Light-Absorbing Gold Microparticles.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25705949" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : A review of hand-held, home-use cosmetic laser and light devices.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18786500" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Superficial chemical peels and microdermabrasion for acne vulgaris.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18053051" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Comparison of alpha- and beta-hydroxy acid chemical peels in the treatment of mild to moderately severe facial acne vulgaris.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10343939" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Glycolic acid peeling in the treatment of acne.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14725662" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Salicylic acid peels for the treatment of acne vulgaris in Asian patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9935087" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11298700" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : The use of microdermabrasion for acne: a pilot study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15799680" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Microdermabrasion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17373171" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Efficacy of microdermabrasion preceding ALA application in reducing the incubation time of ALA in laser PDT.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17373171" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Efficacy of microdermabrasion preceding ALA application in reducing the incubation time of ALA in laser PDT.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6222700" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Intralesional corticosteroids in the treatment of nodulocystic acne.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6222700" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Intralesional corticosteroids in the treatment of nodulocystic acne.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20466169" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Thermotherapy in dermatologic infections.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
